Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine hydrochloride injection vs Ketanest S for general anesthesia in laparoscopic surgery
CTR20212250Phase 3Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esketamine, sponsored by Yangtze River Pharmaceutical Group. Started Sep 2021; status: completed.
02
Drugs
esketamine
Beyond the preview
Go deeper on CTR20212250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212250.